Abstract
Nonulcer dyspepsia (NUD) is a generic term used to describe the presence of dyspeptic symptoms in patients unaffected by pancreatic or biliary disorders (i.e., with normal abdominal ultrasound), without endoscopic signs of peptic ulcer disease or reflux esophagitis, and no symptoms clearly suggestive of irritable bowel syndrome.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kairaluoma M, Hentilae R, Alavaikko M, et al: Sucralfate versus placebo in the treatment of nonulcer dyspepsia. Am J Med 83(suppl 3B):51–55, 1987. A major study on the use of sucralfate in dyspeptic patients with either organic or functional forms of dyspepsia.
Barbara L, Biasco G, Capurso L, et al: Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients. Am J Gastroenterol 85:1109–1113, 1990. An important study on the effects of sucralfate on histological gastritis and on the (lack of) relation to H. pylori infection.
Psilogenis M, Nazzari M, Ferrari PA: A multicenter double-blind study of sulglycotide versus sucralfate in nonulcer dyspepsia. Int J Clin Pharmacol Ther Toxicol 28:369–374, 1990. Possibly the only published study where the efficacy of sucralfate in nonulcer dyspepsia has been compared with that of an active drug.
Skoubo-Kristensen E, Funch-Jensen P, Kruse A, et al Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis. Scand J Gastroenterol 24:716–720, 1989. The only example of negative results of sucralfate in the treatment of gastritis. A matter of type-2 error?
Guslandi M: Comparison of sucralfate and ranitidine in the treatment of chronic nonerosive gastritis. A randomized, multicenter trial. Am J Med 86(suppl 6A):45–48, 1989. The largest trial on the treatment of gastritis with sucralfate and the only one directly comparing the drug with an H2-receptor antagonist as regards clinical, endoscopic, and histological results.
Guslandi M, Ballarin E, Fanti L, et al: Follow-up of endoscopie gastritis after healing with sucralfate or an H2-receptor antagonist. Scand J Gastroenterol 27(suppl 191):25–27, 1992. Probably the first attempt to investigate the outcome of endoscopie gastritis after healing by pharmacological agents.
Guslandi M, Molteni V, Dell’Oca M, et al: Double-blind trial of pirenzepine versus sucralfate in the treatment of endoscopie duodenitis. Clin Ther 12:26–30, 1990. The only source of information on the potential role of sucralfate in the treatment of duodenitis.
Safrany L. Schott B: Vergleich von Sucralfat und Antazida in der Behandlung der unspezifischen erosivhamorrhagischen Duodenitis. Therapiewoche 33:5233–5236, 1983. The first data, although scarce and only preliminary, on the possible use of sucralfate in erosive lesions.
Guslandi M, Ballarin E, Tittobello A: Rioprostil in the treatment of duodenal erosions. Scand J Gastroenterol 24(suppl 164): 174–177, 1989. The only published comparative study of sucralfate and a prostaglandin analogue in duodenal erosions.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Plenum Press
About this chapter
Cite this chapter
Guslandi, M. (1995). Sucralfate in Nonulcer Dyspepsia, Gastritis, and Duodenitis. In: Hollander, D., Tytgat, G.N.J. (eds) Sucralfate. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-32154-7_30
Download citation
DOI: https://doi.org/10.1007/978-0-585-32154-7_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44740-2
Online ISBN: 978-0-585-32154-7
eBook Packages: Springer Book Archive